Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital.

× No keyword cloud information.

19 in total

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

Review 2. Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors: K Lauritsen; L S Laursen; J Rask-Madsen
Journal: Clin Pharmacokinet Date: 1990-08 Impact factor: 6.447

Review 3. Survey of the human acetylator polymorphism in spontaneous disorders.

Authors: D A Evans
Journal: J Med Genet Date: 1984-08 Impact factor: 6.318

Review 4. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors: U Klotz
Journal: Clin Pharmacokinet Date: 1985 Jul-Aug Impact factor: 6.447

5. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.

Authors: A K Azadkhan; S C Truelove; J K Aronson
Journal: Br J Clin Pharmacol Date: 1982-04 Impact factor: 4.335

6. Sulphasalazine and male infertility: reversibility and possible mechanism.

Authors: S Toovey; E Hudson; W F Hendry; A J Levi
Journal: Gut Date: 1981-06 Impact factor: 23.059

7. Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazone.

Authors: H A Strong; R Angus; J Oates; J Sembi; P Howarth; A G Renwick; C F George
Journal: Clin Pharmacokinet Date: 1986 Sep-Oct Impact factor: 6.447

8. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis.

Authors: A J Taggart; B J McDermott; S D Roberts
Journal: Clin Pharmacokinet Date: 1992-10 Impact factor: 6.447

9. Stability of disodium azodisalicylate (olsalazine) and metabolites in urine and faeces stored at different temperatures.

Authors: R A van Hogezand; A van Schaik; P A van Hees; J H van Tongeren
Journal: Eur J Drug Metab Pharmacokinet Date: 1988 Oct-Dec Impact factor: 2.441

10. The association of the slow acetylator phenotype with bladder cancer.

Authors: D A Evans; L C Eze; E J Whibley
Journal: J Med Genet Date: 1983-10 Impact factor: 6.318